MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease

J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni (Rochester, USA)

Meeting: 2023 International Congress

Abstract Number: 238

Keywords: Parkinson’s

Category: Parkinson's Disease and Lewy Body Dementia

Objective: To develop a consensus based conceptual model of meaningful symptoms and impacts in early Parkinson’s disease (PD) through aligning of PD qualitative research carried out to date.

Background: There is an urgent need to develop novel patient centric clinical outcome assessments (COA) relevant to meaningful aspects of health at different stages of PD. PD is a phenotypically heterogenous disease with substantial variation in symptom presentation, particularly in early-stages. Recent qualitative studies have helped to increase understanding of what is important to patients with PD, but theoretically informed conceptual models that can guide development and selection of COAs are currently lacking. Thus, a clear, widely accepted model of symptoms and impacts for PD is urgently needed to guide research at each stage.

Method: In collaboration with the Michael J Fox Foundation for Parkinson’s, Critical Path Institute, people with PD, and academic and industry stakeholders, we have established a task force to develop a patient-centered consensus conceptual model of meaningful aspects of health for early-stage PD, with a focus on delineating key symptoms and impacts.  The task force was launched in March 2023.  The task force aims to: (1) review existing literature and identify sources for inclusion; (2) curate currently recognized concepts of interest and identify gaps; (3) grade existing evidence to develop recommendations for high priority items; and (4) develop a consensus conceptual model that can guide future research.

Results: Target date for project completion is March 2024.

Conclusion: Strong theoretical underpinnings are needed to unify approaches to development of patient centric meaningful COAs. A consensus conceptual model will help to identify current high priority areas and potential gaps in knowledge for future research in early PD. Collaboration of the key stakeholders is an essential part of this process.

To cite this abstract in AMA style:

J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni. Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/building-a-consensus-conceptual-model-of-meaningful-symptoms-and-impacts-in-early-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/building-a-consensus-conceptual-model-of-meaningful-symptoms-and-impacts-in-early-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley